ABSTRACT
Aim To perform an independent validation of deep learning (DL) algorithms for automated scleral spur detection and measurement of scleral spur-based biometric parameters in anterior segment optical coherence tomography (AS-OCT) images.
Methods Patients receiving routine eye care underwent AS-OCT imaging using the ANTERION OCT system (Heidelberg Engineering, Heidelberg, Germany). Scleral spur locations were marked by three human graders (Reference, Expert, and Novice) and predicted using DL algorithms developed by Heidelberg Engineering that prioritize a false positive rate <4% (FPR4) or true positive rate >95% (TPR95). Performance of human graders and DL algorithms were evaluated based on agreement of scleral spur locations and biometric measurements with the Reference Grader.
Results 1,308 AS-OCT images were obtained from 117 participants. Median differences in scleral spur locations from reference locations were significantly smaller (p<0.001) for the FPR4 (52.6±48.6μm) and TPR95 (55.5±50.6μm) algorithms compared to the Expert (61.1±65.7μm) and Novice (79.4±74.9μm) Graders. Inter-grader reproducibility of biometric measurements was excellent overall for all four (intraclass correlation coefficient [ICC] range 0.918-0.997). Inter-grader reproducibility of the Expert Grader [0.567-0.965] and DL algorithms [0.746-0.979] exceeded that of the Novice Grader [0.146-0.929] for images with narrow angles, defined as angle opening distance 500μm from the scleral spur (AOD500) <150μm.
Conclusions DL algorithms on the ANTERION approximate expert-level measurement of scleral spur-based biometric parameters in an independent patient population. These algorithms could enhance clinical utility of AS-OCT imaging, especially for evaluating patients with angle closure and performing intraocular lens (IOL) calculations.
What is already known on this topic Deep learning (DL) algorithms can detect scleral spur locations in AS-OCT images with expert-level performance; however, there is sparse information about the accuracy of AS-OCT measurements associated with these predicted scleral spur locations.
What this study adds DL algorithms on the ANTERION OCT system (Heidelberg Engineering, Heidelberg, Germany) approximate expert-level detection of the scleral spur and measurement of anterior segment biometric parameters in a real-world clinical cohort. Performance of the algorithms generally exceeds that of a novice grader.
How this study might affect research, practice or policy The automation of scleral spur detection and quantitative biometric analysis overcomes the time-and expertise-dependent nature of AS-OCT imaging in the clinical setting. This technology provides clinicians with convenient access to data that could enhance care of patients with angle closure disease or patients receiving intraocular lens implantation.
Competing Interest Statement
K.B., G.A., A.A.P., B.B., and X.X. have no relevant financial disclosures. B.Y.X. and A.S.H. receive research support from Heidelberg Engineering. M.S. is employed by Heidelberg Engineering.
Funding Statement
This work was supported by grant K23 EY029763 from the National Eye Institute, National Institute of Health, Bethesda, Maryland and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness, New York, NY.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of the University of Southern California (USC) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is not available
